Sort by
Refine Your Search
-
Program
-
Field
-
medicine imaging and therapy is available in the research team led by S. Graves in the division of Nuclear Medicine, Department of Radiology, University of Iowa. Research activities anticipated include
-
control for iPSC lines. • Establish and optimize experimental protocols and analytic pipelines for assays (e.g., imaging-based biomarker assays, metabolic flux assays), multiomics profiling, and
-
during pathological conditions. 2. Neonatal seizures and epilepsy 3. GABAA receptor physiology. We approach these research areas with electrophysiological and imaging. The Postdoctoral researcher will be
-
Department:Radiology Salary Salary:$50,004.00 to Commensurate Position Details Full/Part Time Status:Full Time Percent Time:100% Position Description: Post-Doctoral Research Fellow in Quantitative Brain Imaging The MR
-
, biology, and medicine? We’re seeking a talented Scientist to join our dynamic team! Our mission is to develop novel PET imaging agents for widely metastatic cancers and to develop novel radioligand
-
imaging methods and metabolic function tests to assess airway epithelial function and neuronal health. This is a non-tenure track position, and the appointment length will coincide with available funding
-
TMS systems and has access to the University of Iowa’s cutting-edge imaging facility, which includes research-dedicated human 3T and 7T fMRI scanners. The lab maintains active collaborations with
-
(transcranial magnetic stimulation (TMS), intracranial electrical stimulation (iES)) concurrent with functional magnetic resonance imaging (fMRI) or intracranial electroencephalography (iEEG), and brain lesion
-
disease states. The candidate will also have the opportunity to work with state-of-the-art equipment such as a small animal radiation research platform (SARRP),cabinet irradiators, and in vivo imagers
-
, modified Paleolithic diet and usual diet (with Dietary Guidelines for Americans information) diets in the setting of multiple sclerosis, which will include biomarkers and brain imaging at baseline and after